- Home
- HDSN vs NMRA Comparison
HDSN vs NMRA Comparison
Compare HDSN & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HDSN | NMRA |
|---|---|---|
| Founded | 1991 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.0M | 302.0M |
| IPO Year | 1996 | 2023 |
Fundamental Metrics
Financial Performance| Metric | HDSN | NMRA |
|---|---|---|
| Price | $5.67 | $1.74 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $9.00 | $7.50 |
| AVG Volume (30 Days) | 437.7K | ★ 614.5K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 5.23 |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $237,118,000.00 | N/A |
| Revenue This Year | $2.51 | N/A |
| Revenue Next Year | $2.38 | N/A |
| P/E Ratio | $46.67 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.64 | $0.83 |
| 52 Week High | $10.52 | $3.65 |
Technical Indicators
Market Signals| Indicator | HDSN | NMRA |
|---|---|---|
| Relative Strength Index (RSI) | 43.56 | 57.92 |
| Support Level | $5.55 | $1.67 |
| Resistance Level | $6.48 | $1.85 |
| Average True Range (ATR) | 0.26 | 0.10 |
| MACD | -0.07 | 0.01 |
| Stochastic Oscillator | 18.04 | 83.61 |
Price Performance
Historical ComparisonAbout HDSN Hudson Technologies Inc.
Hudson Technologies Inc is a refrigerant services company providing solutions to recurring challenges within the refrigeration industry. The company delivers environmentally sustainable offerings, covering the sale of refrigerant gases, recovery, reclamation, and reuse, as well as improving equipment performance through energy efficiency services, emergency air conditioning and refrigeration system repairs, refrigerant disposal, and carbon credit trading. It operates through one reportable segment. Its products and services are used in commercial air conditioning, industrial processing, and refrigeration systems, and include refrigerant and industrial gas sales, refrigerant management services (mainly reclamation of refrigerants), and RefrigerantSide services performed at customer sites.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.